Is the Magnificent 7 About to Become 8?
The question sounds like speculation. We think it's a structural diagnosis. The original seven earned their designation through category monopoly — each one became the unavoidable layer in its domain.
Read full analysisWhy Entrepreneurial Companies Outperform the Competition
Abstract Various traits differentiate entrepreneurs from non-entrepreneurs, making the former successful and the latter more likely to face...
New Name, Same Old Gains for the ERShares ENTR ETF
The ERShares Entrepreneurs ETF (ENTR) has a new name, but it’s still backed by the same compelling strategy. ENTR tries to...
Looking for New Factor-Based Strategies? Look No Further than ‘ENTR’
The ERShares Entrepreneurs ETF (ENTR) is a fund investors will want to consider this year, particularly those looking for a...
Procure the Entrepreneurs: The Enterprising ENTR ETF
Treasury yields are rising, making an already tricky fixed income environment all the more thorny to navigate....
An Equity Decline is Just Fine for This Entrepreneurial ETF
A Treasury market gone haywire is weighing on riskier assets, but equity declines could bring opportunity with...
The Gains Are Abroad. And Not Where You Might Think
Data confirm investors are pouring cash into international equity funds, a scenario that bodes well for the ERShares...
ENTR’s Quality Growth Proposition Is Getting More Attractive
Amid raucous market action, the bulk of which is being caused by rising Treasury yields, the ERShares Entrepreneurs...
Believe It or Not, But Growth May Be the Real Value Destination
Suddenly, value stocks are generating plenty of buzz, some at the expense of their growth rivals. However,...
Why Growth Is Offering More Value than Meets the Eye
For the first time in what feels like an eternity, value stocks are topping their growth rivals,...
ERShares Blogs and Insights on Entrepreneurial Investing
The ERShares blogs and insights hub is your central resource for research, commentary, and analysis on entrepreneurial investing trends. Published by the ERShares research team, these articles cover market developments, portfolio strategy updates, and deep dives into the Entrepreneur Factor methodology that drives all ERShares investment decisions. Whether you are a financial advisor, institutional allocator, or individual investor, the ERShares blogs and insights library offers timely perspectives grounded in proprietary data.
Topics span the full range of entrepreneurial investing themes: founder-led company performance, sector rotation signals, global market outlooks, and innovation-driven growth opportunities. Each post draws on data from NASDAQ, Bloomberg, and internal ERShares research to provide actionable context rather than surface-level commentary.
What You Will Find in Our Research Library
Regular content categories include quarterly market reviews, Entrepreneur Factor scoring updates, thematic research on sectors like technology and healthcare, and thought leadership on the structural advantages of founder-led businesses. The ERShares blogs and insights section also features commentary on macroeconomic events and their implications for entrepreneurial companies held within products like the XOVR ETF and the ENTIX fund.
Financial advisors frequently use these posts as client-facing educational resources, sharing specific articles to illustrate the investment thesis behind an entrepreneurial allocation. The writing balances analytical depth with accessibility, making complex topics approachable for a broad audience without sacrificing rigor.
Stay Informed with ERShares Research
Staying current with entrepreneurial investing research gives investors an informational edge when evaluating portfolio decisions. The archive is searchable by topic, date, and investment vehicle, making it easy to find relevant analysis on demand. For those who prefer proactive delivery, subscribing to the ERShares newsletter ensures new posts arrive directly in your inbox.
Browse the latest articles below, explore the ERShares Indexes for benchmark performance data, or contact ERShares to discuss any research topic in greater detail with our team.
